Evaluation Of Psychiatric Complaints And Diagnoses Associated With Skin Diseases: A Cross-Sectional Study

Abstract

Objective: Skin diseases can impact social and psychological well-being alongside physical health. This study examined psychiatric follow-up rates and psychiatric complaints in dermatologic patients. Materials and Methods: A total of 791 patients from Dermatology outpatient clinic (July 2022–January 2023) participated. They completed a sociodemographic form and a psychiatric complaint screening list. Results: Of the participants, 496 (63.7%) were female, and 295 (37.3%) were male. The most common dermatologic conditions were acneiform (27.9%), inflammatory (19.2%), and infectious (17.2%) dermatoses. Psychiatric follow-up history was reported in 93 (11.8%) patients, while 112 (14.2%) used psychiatric medication. Depressive mood was the most frequent psychiatric complaint (50%), followed by anxiety (30%) and obsessive-compulsive symptoms. Conclusion: Studies suggest psychiatric issues contribute to the onset or worsening of skin diseases. The high prevalence of depressive mood in dermatologic patients highlights the need for psychiatric evaluation, which could improve treatment outcomes and quality of life. Keywords: Dermatologic diseases, Psychiatric complaints, Psychiatric comorbidity

Keywords

• Dermatologic diseases
• Psychiatric complaints
• Psychiatric comorbidity

Cilt Hastalıklarıyla İlişkili Psikiyatrik Şikayet ve Tanıların Değerlendirilmesi: Kesitsel Bir Çalışma

Abstract

Amaç: Deri hastalıklarının fiziksel sağlık üzerindeki etkilerinin yanı sıra sosyal ve psikolojik sorunlara da yol açabileceği bilinmektedir. Bu çalışmada, dermatolojik hastalıkları olan bireylerde psikiyatrik takip oranları ve psikiyatrik şikayetlerin frekansını belirlemeyi amaçlanmıştır. Gereç ve Yöntem: Çalışma, Temmuz 2022 ile Ocak 2023 tarihleri arasında Balıkesir Atatürk Şehir Hastanesi Dermatoloji polikliniğine başvuran 791 hastayı içermektedir. Hastalara, araştırmacılar tarafından düzenlenen sosyodemografik bilgi formu ve yaygın psikiyatrik şikayet kategorilerinin bulunduğu bir tarama listesi uygulanmıştır. Bulgular: oplamda 791 hasta çalışmaya dahil edilmiştir (496 kadın, %63,7; 295 erkek, %37,3). En yaygın dermatolojik tanılar akneiform (%27,9), enflamatuar (%19,2) ve enfeksiyöz (%17,2) dermatozlar olmuştur. Psikiyatrik takibi olan hasta oranı %11,8 (n=93) ve psikiyatrik ilaç kullanım oranı %14,2 (n=112) olarak bulunmuştur. En sık bildirilen psikiyatrik şikayet depresif ruh hali (%50) olup, bunu kaygı belirtileri ve obsesif-kompulsif şikayetler (%30) takip etmiştir. Sonuç: Çeşitli çalışmalar, psikiyatrik problemlerinin birçok deri hastalığının başlangıcında veya alevlenmesinde rol oynayabileceğini göstermiştir. Dermatolojik hastalığı olan hastaların yarısında depresif ruh hali bulunması, psikiyatrik değerlendirmenin tedavi başarısını ve hastaların yaşam kalitesini olumlu yönde etkileyebileceğini göstermektedir. Anahtar Kelimeler: Dermatolojik hastalıklar, Psikiyatrik şikayetler, Psikiyatrik komorbidite

Keywords

• Dermatolojik hastalıklar
• Psikiyatrik şikayetler
• Psikiyatrik komorbidite

References

1. Aktan, Ş., Özmen, E., & Şanlı, B. (1998). Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology, 197(3), 230–234.
2. Attah Johnson, F. Y., & Mostaghimi, H. (1995). Co-morbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. International Journal of Dermatology, 34(4), 244–248.
3. Bilgiç, A., & Bilgiç, Ö. (2012). Çocuk ve ergenlerde psikofizyolojik kökenli psikodermatozlar. Selçuk Tıp Dergisi, 28(4), 264–266.
4. Cash, T. F., Price, V. H., & Savin, R. C. (1993). Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects. Journal of the American Academy of Dermatology, 29(4), 568–575. https://doi.org/10.1016/0190-9622(93)70223-G
5. Chen, G. F., Chaitoff, A., Yeung, H., Thompson, W. K., & Wu, J. J. (2023). Obsessive-compulsive disorder among patients with atopic dermatitis: A case-control study in the All of Us research program. Archives of Dermatological Research, 316(1), 11.
6. Chou, Y. J., Huang, S. T., Su, V. Y. F., Sung, F. C., & Yeh, C. B. (2022). Obsessive-compulsive disorder and the associated risk of autoimmune skin diseases: A nationwide population-based cohort study. CNS Spectrums, 1–7. https://doi.org/10.1017/S1092852922000257
7. Fritzsche, K., Hackl, P., Müller, M., Zwielehner, J., Burger, B., Staudenmaier, R., & Wirsching, M. (2001). Psychosomatic Liaison Service in Dermatology: Need for psychotherapeutic interventions and their realization. Dermatology, 203(1), 27–31. https://doi.org/10.1159/000051718
8. Harth, W., Mayer, K., & Linse, R. (2004). The borderline syndrome in psychosomatic dermatology: Overview and case report. Journal of the European Academy of Dermatology and Venereology, 18(4), 503–507. https://doi.org/10.1111/j.1468-3083.2004.00974.x

9. Hughes, J. E., Barraclough, B. M., Hamblin, L. G., & White, J. E. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51–54. https://doi.org/10.1192/bjp.143.1.51
10. Hughes, O., Hutchings, P. B., & Phelps, C. (2022). Stigma, social appearance anxiety and coping in men and women living with skin conditions: A mixed methods analysis. Skin Health and Disease, 2(4), e73. https://doi.org/10.1002/ski2.73
11. Jafferany, M., Franca, K., & Fernandez, G. (2010a). Psychocutaneous disorders: A survey study of psychiatrists' awareness and treatment patterns. Southern Medical Journal, 103(12), 1199–1203. https://doi.org/10.1097/SMJ.0b013e3181f03316
12. Jafferany, M., Szepietowski, J. C., & Reich, A. (2010b). The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: Results of a survey study. International Journal of Dermatology, 49(7), 784–789. https://doi.org/10.1111/j.1365-4632.2009.04413.x
13. Jalenques, I., Cruz, B. A., Auclair, C., Maruani, A., & Dauchy, S. (2020). The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis. Journal of the American Academy of Dermatology, 83(2), 542–553. https://doi.org/10.1016/j.jaad.2020.02.049
14. Kannan, S., Shuai, B., & Thiyagarajan, A. (2013). The role of tumor necrosis factor-alpha and other cytokines in depression: What dermatologists should know. Journal of Dermatological Treatment, 24(2), 148–152. https://doi.org/10.3109/09546634.2012.674975
15. Khan, M. Z., Naeem, A., & Mufti, K. A. (2001). Prevalence of mental health problems in acne patients. Journal of Ayub Medical College Abbottabad, 13(4), 7–8.
16. Kolkhir, P., Grakhova, M., Pogorelov, D., & Maurer, M. (2024). Chronic spontaneous urticaria: A review. JAMA, 332(17), 1464–1477. https://doi.org/10.1001/jama.2024.1267
17. Koo, J., & Lebwohl, A. (2001). Psychodermatology: The mind and skin connection. American Family Physician, 64(11), 1873–1878.
18. Kökçam, İ., & Dilek, N. (2010). Dermatoloji kliniğinde tedavi gören hastalar için istenen psikiyatri konsültasyonları. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, 24(1), 21–24.
19. Kussainova, A., Kosherbayeva, A., Bekniyazov, I., Akhmetova, A., & Plzak, J. (2020). Vitiligo and anxiety: A systematic review and meta-analysis. PLoS ONE, 15(11), e0241445. https://doi.org/10.1371/journal.pone.0241445
20. Millington, G. W. M., & Palmer, H. E. (2023). Proopiomelanocortin (POMC) and psychodermatology. Skin Health and Disease, 3(3), e201. https://doi.org/10.1002/ski2.201
21. Pärna, E., Aluoja, A., & Kingo, K. (2015). Quality of life and emotional state in chronic skin disease. Acta Dermato-Venereologica, 95(3), 312–316. https://doi.org/10.2340/00015555-1981
22. Peters, E. M. J. (2016). Stressed skin? A molecular psychosomatic update on stress-causes and effects in dermatologic diseases. Journal der Deutschen Dermatologischen Gesellschaft, 14(3), 233–252. https://doi.org/10.1111/ddg.12958
23. Picardi, A., Abeni, D., Melchi, C. F., Puddu, P., & Pasquini, P. (2000). Psychiatric morbidity in dermatological outpatients: An issue to be recognized. British Journal of Dermatology, 143(5), 983–991. https://doi.org/10.1046/j.1365-2133.2000.03831.x
24. Picardi, A., Abeni, D., Pasquini, P., & Puddu, P. (2003). Treatment outcome and incidence of psychiatric disorders in dermatological outpatients. Journal of the European Academy of Dermatology and Venereology, 17(2), 155–159. https://doi.org/10.1046/j.1468-3083.2003.00640.x
25. Salzer, B. A., & Schallreuter, K. U. (1995). Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology, 190(2), 109–115. https://doi.org/10.1159/000246491
26. Samuels, D. V., Rosenthal, A. N., Lin, R., Chaudhari, S., & Natsuaki, M. N. (2020). Acne vulgaris and risk of depression and anxiety: A meta-analytic review. Journal of the American Academy of Dermatology, 83(2), 532–541. https://doi.org/10.1016/j.jaad.2020.02.047
27. Wang, J., Wu, X., Lai, W., Long, E., Zhang, X., Li, W., Zhu, Y., Chen, C., & Hou, J. (2017). Prevalence of depression and depressive symptoms among outpatients: A systematic review and meta-analysis. BMJ Open, 7(8), e017173. https://doi.org/10.1136/bmjopen-2017-017173
28. Wessely, S. C., & Lewis, G. H. (1989). The classification of psychiatric morbidity in attenders at a dermatology clinic. British Journal of Psychiatry, 155(5), 686–691. https://doi.org/10.1192/bjp.155.5.686
29. Yildiz Miniksar, D. (2015). Dermatolojik hastalığı olan çocuk ve ergenlerde görülen psikiyatrik bozukluklar. Archives of Clinical Psychiatry (São Paulo), 42(4), 105–110.